U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Acneiform dermatitis

MedGen UID:
68607
•Concept ID:
C0234894
•
Disease or Syndrome
Synonyms: Acneiform Dermatitis; acneiform dermatitis; Rash acneiform
 
Monarch Initiative: MONDO:0006521

Definition

Cutaneous eruptions resembling acne, characterized by the presence of papulonodules, pustules, comedones, or cysts in the face, trunk, and extremities. Causes include infections and the use of certain medications (e.g., antibiotics and steroids). [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVAcneiform dermatitis

Professional guidelines

PubMed

Serum creatine kinase elevation following tyrosine kinase inhibitor treatment in cancer patients: Symptoms, mechanism, and clinical management.
Zhang H, To KKW
Clin Transl Sci 2024 Nov;17(11):e70053. doi: 10.1111/cts.70053. PMID: 39473122Free PMC Article
The EMA assessment of encorafenib in combination with cetuximab for the treatment of adult patients with metastatic colorectal carcinoma harbouring the BRAFV600E mutation who have received prior therapy.
Trullas A, Delgado J, Koenig J, Fuerstenau U, Dedorath J, Hausmann S, Stock T, Enzmann H, Pignatti F
ESMO Open 2021 Feb;6(1):100031. Epub 2021 Jan 8 doi: 10.1016/j.esmoop.2020.100031. PMID: 33422765Free PMC Article
Differential diagnosis of facial acne on black skin.
Poli F
Int J Dermatol 2012 Nov;51 Suppl 1:24-6, 27-9. doi: 10.1111/j.1365-4632.2012.05559.x. PMID: 23210948

Recent clinical studies

Etiology

Older patients with EGFR mutation-positive non-small cell lung cancer treated with afatinib in clinical practice: A subset analysis of the non-interventional GIDEON study.
Brueckl WM, Reck M, Schäfer H, Neben K, Griesinger F, Rawluk J, Krüger S, Kokowski K, Ficker JH, Möller M, Schueler A, Laack E
J Geriatr Oncol 2023 Jan;14(1):101394. Epub 2022 Oct 30 doi: 10.1016/j.jgo.2022.10.009. PMID: 36323612
Results of the non-small cell lung cancer part of a phase III, open-label, randomized trial evaluating topical corticosteroid therapy for facial acneiform dermatitis induced by EGFR inhibitors: stepwise rank down from potent corticosteroid (FAEISS study, NCCH-1512).
Nishino K, Fujiwara Y, Ohe Y, Saito R, Miyauchi E, Kobayashi T, Nakai Y, Takahashi T, Shibata T, Hamaguchi T, Kikuchi K, Yamazaki N, Fukuda H, Nozawa K, Kiyohara Y
Support Care Cancer 2021 May;29(5):2327-2334. Epub 2020 Sep 11 doi: 10.1007/s00520-020-05765-7. PMID: 32918131Free PMC Article
Risk of selected dermatological toxicities in cancer patients treated with MEK inhibitors: a comparative systematic review and meta-analysis.
Abdel-Rahman O, ElHalawani H, Ahmed H
Future Oncol 2015;11(24):3307-19. Epub 2015 Nov 12 doi: 10.2217/fon.15.265. PMID: 26561878
MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study.
Ascierto PA, Schadendorf D, Berking C, Agarwala SS, van Herpen CM, Queirolo P, Blank CU, Hauschild A, Beck JT, St-Pierre A, Niazi F, Wandel S, Peters M, Zubel A, Dummer R
Lancet Oncol 2013 Mar;14(3):249-56. Epub 2013 Feb 13 doi: 10.1016/S1470-2045(13)70024-X. PMID: 23414587
Safety and pharmacokinetics of panitumumab in Japanese patients with advanced solid tumors.
Doi T, Ohtsu A, Tahara M, Tamura T, Shirao K, Yamada Y, Otani S, Yang BB, Ohkura M, Ohtsu T
Int J Clin Oncol 2009 Aug;14(4):307-14. Epub 2009 Aug 25 doi: 10.1007/s10147-008-0855-2. PMID: 19705240

Diagnosis

Facial dermatitis in a healthy 9-year-old boy.
Hiep A, Gross E
JAAPA 2022 Sep 1;35(9):37-40. doi: 10.1097/01.JAA.0000854540.40254.d0. PMID: 36007117
Inhibition of EGFR, HER2, and HER3 signaling with AZD8931 in combination with anastrozole as an anticancer approach: Phase II randomized study in women with endocrine-therapy-naïve advanced breast cancer.
Johnston S, Basik M, Hegg R, Lausoontornsiri W, Grzeda L, Clemons M, Dreosti L, Mann H, Stuart M, Cristofanilli M
Breast Cancer Res Treat 2016 Nov;160(1):91-99. Epub 2016 Sep 21 doi: 10.1007/s10549-016-3979-5. PMID: 27654971
Differential diagnosis of facial acne on black skin.
Poli F
Int J Dermatol 2012 Nov;51 Suppl 1:24-6, 27-9. doi: 10.1111/j.1365-4632.2012.05559.x. PMID: 23210948
Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.
Passarini B, Infusino SD, Barbieri E, Varotti E, Gionchetti P, Rizzello F, Morselli C, Tambasco R, Campieri M
Dermatology 2007;215(4):295-300. doi: 10.1159/000107622. PMID: 17911986
Chronic granulomatous disease: two members of a single family with different dermatologic manifestations.
Luis-Montoya P, Sáez-de Ocariz Mdel M, Vega-Memije ME
Skinmed 2005 Sep-Oct;4(5):320-2. doi: 10.1111/j.1540-9740.2005.03927.x. PMID: 16282759

Therapy

Efficacy, safety and genomic analysis of SCT200, an anti-EGFR monoclonal antibody, in patients with fluorouracil, irinotecan and oxaliplatin refractory RAS and BRAF wild-type metastatic colorectal cancer: a phase Ⅱ study.
Yang L, Zhang W, Fan N, Cao P, Cheng Y, Zhu L, Luo S, Zong H, Bai Y, Zhou J, Deng Y, Ba Y, Liu T, Aili M, Yin X, Gu K, Dai G, Ying J, Shi J, Gao Y, Li W, Yu G, Xie L, Gai W, Wang Y, Meng P, Shi Y
EBioMedicine 2024 Feb;100:104966. Epub 2024 Jan 13 doi: 10.1016/j.ebiom.2024.104966. PMID: 38217945Free PMC Article
Results of an open-label phase 1b study of the ERK inhibitor MK-8353 plus the MEK inhibitor selumetinib in patients with advanced or metastatic solid tumors.
Stathis A, Tolcher AW, Wang JS, Renouf DJ, Chen LC, Suttner LH, Freshwater T, Webber AL, Nayak T, Siu LL
Invest New Drugs 2023 Jun;41(3):380-390. Epub 2023 Apr 11 doi: 10.1007/s10637-022-01326-3. PMID: 37040046Free PMC Article
Results of the non-small cell lung cancer part of a phase III, open-label, randomized trial evaluating topical corticosteroid therapy for facial acneiform dermatitis induced by EGFR inhibitors: stepwise rank down from potent corticosteroid (FAEISS study, NCCH-1512).
Nishino K, Fujiwara Y, Ohe Y, Saito R, Miyauchi E, Kobayashi T, Nakai Y, Takahashi T, Shibata T, Hamaguchi T, Kikuchi K, Yamazaki N, Fukuda H, Nozawa K, Kiyohara Y
Support Care Cancer 2021 May;29(5):2327-2334. Epub 2020 Sep 11 doi: 10.1007/s00520-020-05765-7. PMID: 32918131Free PMC Article
Risk of selected dermatological toxicities in cancer patients treated with MEK inhibitors: a comparative systematic review and meta-analysis.
Abdel-Rahman O, ElHalawani H, Ahmed H
Future Oncol 2015;11(24):3307-19. Epub 2015 Nov 12 doi: 10.2217/fon.15.265. PMID: 26561878
Dehydroepiandrosterone in systemic lupus erythematosus.
van Vollenhoven RF
Rheum Dis Clin North Am 2000 May;26(2):349-62. doi: 10.1016/s0889-857x(05)70142-3. PMID: 10768216

Prognosis

Serum creatine kinase elevation following tyrosine kinase inhibitor treatment in cancer patients: Symptoms, mechanism, and clinical management.
Zhang H, To KKW
Clin Transl Sci 2024 Nov;17(11):e70053. doi: 10.1111/cts.70053. PMID: 39473122Free PMC Article
Efficacy, safety and genomic analysis of SCT200, an anti-EGFR monoclonal antibody, in patients with fluorouracil, irinotecan and oxaliplatin refractory RAS and BRAF wild-type metastatic colorectal cancer: a phase Ⅱ study.
Yang L, Zhang W, Fan N, Cao P, Cheng Y, Zhu L, Luo S, Zong H, Bai Y, Zhou J, Deng Y, Ba Y, Liu T, Aili M, Yin X, Gu K, Dai G, Ying J, Shi J, Gao Y, Li W, Yu G, Xie L, Gai W, Wang Y, Meng P, Shi Y
EBioMedicine 2024 Feb;100:104966. Epub 2024 Jan 13 doi: 10.1016/j.ebiom.2024.104966. PMID: 38217945Free PMC Article
A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours.
Gazzah A, Boni V, Soria JC, Calles A, Even C, Doger B, Mahjoubi L, Bahleda R, Ould-Kaci M, Esler A, Nazabadioko S, Calvo E
Eur J Cancer 2018 Nov;104:1-8. Epub 2018 Oct 1 doi: 10.1016/j.ejca.2018.07.011. PMID: 30278378
Risk of selected dermatological toxicities in cancer patients treated with MEK inhibitors: a comparative systematic review and meta-analysis.
Abdel-Rahman O, ElHalawani H, Ahmed H
Future Oncol 2015;11(24):3307-19. Epub 2015 Nov 12 doi: 10.2217/fon.15.265. PMID: 26561878
Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients.
Sonis S, Treister N, Chawla S, Demetri G, Haluska F
Cancer 2010 Jan 1;116(1):210-5. doi: 10.1002/cncr.24696. PMID: 19862817

Clinical prediction guides

Results of an open-label phase 1b study of the ERK inhibitor MK-8353 plus the MEK inhibitor selumetinib in patients with advanced or metastatic solid tumors.
Stathis A, Tolcher AW, Wang JS, Renouf DJ, Chen LC, Suttner LH, Freshwater T, Webber AL, Nayak T, Siu LL
Invest New Drugs 2023 Jun;41(3):380-390. Epub 2023 Apr 11 doi: 10.1007/s10637-022-01326-3. PMID: 37040046Free PMC Article
Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid Tumors.
Delord JP, Italiano A, Awada A, Aftimos P, Houédé N, Lebbé C, Pages C, Lesimple T, Dinulescu M, Schellens JHM, Leijen S, Rottey S, Kruse V, Kefford R, Faivre S, Gomez-Roca C, Scheuler A, Massimini G, Raymond E
Target Oncol 2021 Jan;16(1):37-46. doi: 10.1007/s11523-020-00768-0. PMID: 33170484
Differential diagnosis of facial acne on black skin.
Poli F
Int J Dermatol 2012 Nov;51 Suppl 1:24-6, 27-9. doi: 10.1111/j.1365-4632.2012.05559.x. PMID: 23210948
Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.
Passarini B, Infusino SD, Barbieri E, Varotti E, Gionchetti P, Rizzello F, Morselli C, Tambasco R, Campieri M
Dermatology 2007;215(4):295-300. doi: 10.1159/000107622. PMID: 17911986
An open study of dehydroepiandrosterone in systemic lupus erythematosus.
van Vollenhoven RF, Engleman EG, McGuire JL
Arthritis Rheum 1994 Sep;37(9):1305-10. doi: 10.1002/art.1780370906. PMID: 7945493

Recent systematic reviews

Doublet BRAF/MEK inhibition versus single-agent BRAF inhibition in the management of BRAF-mutant advanced melanoma, biological rationale and meta-analysis of published data.
Abdel-Rahman O, ElHalawani H, Ahmed H
Clin Transl Oncol 2016 Aug;18(8):848-58. Epub 2015 Oct 30 doi: 10.1007/s12094-015-1438-0. PMID: 26519363
Risk of selected dermatological toxicities in cancer patients treated with MEK inhibitors: a comparative systematic review and meta-analysis.
Abdel-Rahman O, ElHalawani H, Ahmed H
Future Oncol 2015;11(24):3307-19. Epub 2015 Nov 12 doi: 10.2217/fon.15.265. PMID: 26561878

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Reviews

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...